A systematic overview of radiation therapy effects in rectal cancer

Acta Oncologica

Volumn 42, Issue 5-6, 2003, Pages 476-492

  Glimelius, Bengt ^a,f   Grönberg, Henrik ^b   Järhult, Johannes ^c   Wallgren, Arne ^d   Cavallin Ståhl, Eva ^e  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c RYHOV COUNTY HOSPITAL   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; DRUG DOSAGE; SURGERY; TOXICITY; TUMORS;

RANDOMIZED TRIALS;

RADIOTHERAPY;

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; VINCRISTINE;

ACUTE TOXICITY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; FOLLOW UP; HUMAN; MEDICAL LITERATURE; META ANALYSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION RESPONSE; RANDOMIZATION; RECTUM CARCINOMA; RETROSPECTIVE STUDY; REVIEW; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SWEDEN; TREATMENT OUTCOME;

ADULT; AGED; BRACHYTHERAPY; COLECTOMY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; RECTAL NEOPLASMS; RISK ASSESSMENT; SURVIVAL ANALYSIS; SWEDEN; TREATMENT OUTCOME;

EID: 0141525385     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860310012301     Document Type: Review

References (132)

1. Stenbeck M, Rosén M, Holm L-E. Cancer survival in Sweden during three decades 1961-1991. Acta Oncol 1995; 34: 881-91. (O1)
2. Dahlberg M, Glimelius B, Bergström R, Påhlman L. Improved survival in patients with rectal cancer: a population based register study. Br J Surg 1998; 85: 515-20. (O1)
3. Lehander Martling A, Holm T, Rutqvist L-E, Moran BJ, Heald RJ, Cedermark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Lancet 2000; 356: 93-6. (R1/447)
4. Camilleri-Brennan J, Steele RJ. The impact of recurrent rectal cancer on quality of life. Eur J Surg Oncol 2001; 27: 349-53. (P1/25)
5. Blomgren H. Rectal cancer. Acta Oncol 1996; 35 (Suppl 7): 64-74.
6. Boulis-Wassif S. The role of pre-operative adjuvant therapy in the management of borderline operability rectal cancer. Clin Radiol 1982; 33: 353-8. (C3/109)
7. Rider WD, Palmer JA, Mahoney LJ, Robertson CT. Preoperative irradiation in operable cancer of the rectum: report of the Toronto trial. Can J Surg 1977; 20: 335-8. (C3/106)
8. Duncan W, Smith AN, Freedman LS, Alderson MR, Arnott SJ, Bleehen NM. The evaluation of low dose pre-operative x-ray therapy in the management of operable rectal cancer, results of a randomly controlled trial. Br J Surg 1984; 71: 21-5. (C1/824)
9. Sause WT, Pajak TF, Noyes RD, et al. Evaluation of preoperative radiation therapy in operable colorectal cancer. Ann Surg 1994; 220: 668-75. (C3/77)
10. Goldberg PA, Nicholls RJ, Porter NH, Love S, Grimsey JE. Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: reduction in local treatment failure. Eur J Cancer 1994; 30A: 1602-6. (C2/468)
11. Marsh PJ, James RD, Schofield PF. Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma. Results of a prospective, randomized trial. Dis Colon Rectum 1994; 37: 1205-14. (C1/284)
12. Stockholm Rectal Cancer Study Group. Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Cancer 1990; 66: 49-55. (C1/849)
13. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997; 336: 980-7. (C1/1147)
14. Gerard A, Buyse M, Nordlinger B, et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Ann Surg 1988; 208: 606-14. (C1/466)
15. Horn A, Halvorsen JF, Dahl O. Preoperative radiotherapy in operable rectal cancer. Dis Colon Rectum 1990; 33: 823-38. (C2/269)
16. Medical Research Council Rectal Cancer Working Party. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet 1996; 348: 1605-10. (C2/279)
17. Niebel W, Schultz U, Ried M, et al. Five-year results of a prospective randomised study: experience with combined radiotherapy and surgery for primary rectal carcinoma. Recent Results Cancer Res 1988; 110: 111-3. (C3/142)
18. Higgins G, Humphrey E, Dwight R, Roswit B, Lee L, Keehn R. Preoperative radiation and surgery for cancer of the rectum. VASOG Trial II. Cancer 1986; 58: 352-9. (C3/361)
19. Roswit B, Higgins G, Keehn R. Preoperative irradiation for carcinoma of the rectum and rectosigmoid colon: report of a National Veterans Administration randomized study. Cancer 1975; 35: 1597-602. (C3/613)
20. Kligerman MM. Preoperative radiation therapy in rectal cancer. Cancer 1975; 36: 691-5. (C3/31)
21. Kutzner J, Bruckner R, Kempf P. Preoperative radiotherapy in rectal cancer. Strahlentherapie 1984; 160: 236-8. (C3/170)
22. Reis Nero JA, Quilici FA, Reis Jr JA. A comparison of nonoperative vs preoperative radiotherapy in rectal carcinoma. A 10-year randomized trial. Dis Colon Rectum 1989; 32: 702-10. (C3/68)
23. Kapiteijn E, Marijnen CAM, Nagtegaal ID, et al. Preoperative radiotherapy in combination with total mesorectal excision improves local control in resectable rectal cancer. Report from a multicenter randomized trial. For the Dutch Colo Rectal Cancer Group and other cooperative investigators. New Engl J Med 2001; 345: 638-46. (C1/1861)
24. Stearns MW, Deddish MR, Quan SHQ, Leaming RH. Preoperative roentgen therapy for cancer of the rectum and rectosigmoid. Surg Gynecol Obstet 1974; 138: 584-6. (C3/790)
25. Balslev I, Pedersen M, Teglbjaerg PS, et al. Postoperative radiotherapy in Dukes' B and C carcinoma of rectum and rectosigmoid. Cancer 1986; 58: 22-8. (C1/494)
26. Medical Research Council Rectal Cancer Working Party. Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Lancet 1996; 348: 1610-4. (C1/469)
27. Arnaud JP, Nordlinger B, Bosset JF, et al. Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer. Br J Surg 1997; 84: 352-7. (C3/170)
28. Treurniet-Donker AD, J van Putten WL, Wereldsma JCJ, et al. Postoperative radiation therapy for rectal cancer. Cancer 1991; 67: 2042-8. (C3/172)
29. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. New Engl J Med 1985; 312: 1465-72. (C3/202)
30. Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP Protocol R-01. J Natl Cancer Inst 1988; 80: 21-9. (C1/555)
31. Wolmark N, Wieand HS, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 2000; 92: 388-96. (C1/741)
32. Marneghan H, Gray BN, de Zwart J, et al. Adjuvant post-operative radiotherapy in rectal cancer: results from the ANZ bowel cancer trial (Protocol 8202). Australas Radiol 1991; 35: 61-5. (C3/33)
33. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal cancer. New Engl J Med 1991; 324: 709-15. (C2/204)
34. Tveit KM, Guldvog I, Hagen S, et al. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes' B and C rectal cancer. Br J Surg 1997; 84: 1130-5. (C2/144)
35. O'Connell MJ, Martenson JA, Wieand HS, et al. Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994; 331: 502-7. (C1/660)
36. Mansour EG, Lefkopoulou M, Johnson R, Douglass H. A comparison of postoperative adjuvant chemotherapy, radiotherapy or combination therapy in potentially curable resectable rectal carcinoma. An ECOG study Est 4276. Proc Am Soc Clin Oncol 1991; 10: 154 abstr. (C3/237)
37. Fountzilas G, Zisiadis A, Dafni U, et al. Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group. Ann Oncol 1999; 10: 671-6. (C3/220)
38. Tepper JE, O'Connell MJ, Petroni GR, et al. Adjuvant postoperative fluourouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114. J Clin Oncol 1997; 15: 2030-9. (C1/1696)
39. Tepper JE, O'Connell M, Niedzwiecki D, et al. Final Report of INT 0114 - adjuvant therapy in rectal cancer: analysis by treatment, stage and gender. Proc Am Soc Clin Oncol 2001; abstr 489. (C3/1792)
40. Gastrointestinal Tumor Study Group. Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 1992; 10: 549-57. (C1/660)
41. Lee J-H, Lee J-H, Ahn J-H, et al. Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: A preliminary report. J Clin Oncol 2002; 20: 1751-8. (C2/274)
42. Frykholm G, Glimelius B, Påhlman L. Pre- or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993; 36: 564-72. (C1/471)
43. Hyams DM, Masounas EP, Petrelli N, et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum. A progress report of the National Surgical Adjuvant Breast and Bowel Project protocol R-03. Dis Colon Rectum 1997; 40: 131-9. (C3/116)
44. Roh M, Petrelli N, Wieand S, et al. Phase III randomised trial of preoperative versus postoperative multimodality therapy in patients with carcinoma of the rectum (NSABP R-03). Proc Am Soc Clin Oncol 2001; abstr 490. (C3/267)
45. Sauer R, Fietkau R, Wittekind C, et al. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Strahlenther Onkol 2001; 177: 173-81. (C3/628, ongoing)
46. Bosset JF, Horiot JC, Hamers HR et al. Postoperative pelvic radiotherapy with or without elective irradiation of paraaortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy Group. Radiother Oncol 2001; 61: 7-13.(C1/484)
47. Colorectal Cancer Collaborative Group. Adjuvant therapy for rectal cancer: a systematic overview of 8 507 patients from 22 randomised trials. Lancet 2001; 358: 1291-304. (M1/8507)
48. Camma C, Giunta M, Fiorica E, Pagliaro L, Craxi A, Cottone M. Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA 2000; 284: 1008-15. (M2/5974)
49. Munro AJ, Bentley AHM. Adjuvant radiotherapy in operable rectal cancer: a systematic review. Sem Colon & Rectal Surg 2002; 13: 31-42. (M1/9371)
50. Gerard J-R, Baulieux J, Francois Y, et al. The role of radiotherapy in the conservative treatment of rectal carcinoma. Acta Oncol 1998; 37: 247-52. (L1)
51. Enker WE. Total mesorectal excision - the new golden standard of surgery for rectal cancer. Ann Med 1997; 29: 127-33. (O1)
52. MacFarlane JK, Ryall RDH, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-60. (O1)
53. Havenga K, Enker WE, Norstein J, et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1 411 patients. Eur J Surg Oncol 1999; 25: 368-74. (R1/1411)
54. Dahlberg M, Glimelius B, Påhlman L. Changing strategy for rectal cancer is associated with improved outcome. Br J Surg 1999; 86: 379-84. (R1/423)
55. Wibe A, Moller B, Norstein J, et al. A national strategic change in treatment policy for rectal cancer - implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002; 45: 857-66.
56. Arbman G, Nilsson E, Hallbook O, Sjodahl R. Local recurrence following total mesorectal excision for rectal cancer. Br J Surg 1996; 83: 375-9. (O2)
57. Machado M, Goldman S, Järhult J. Improved results in rectal cancer surgery - an effect of specialization? Colorectal Dis 2001; 2: 264-9. (L2)
58. McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. Br Med J 1991; 302: 1501-5. (0)
59. Porter GA, Soskolne CL, Yakimets WW, Newman SC. Surgeon-related factors and outcome in rectal cancer. Ann Surg 1998; 227: 157-67.
60. Herrmann T, Petersen S, Hellmich G, Baumann M, Ludwig K. Spättoxizität nach präoperativer Kurzzeitvorbestrahlung und risikoadaptierter postoperativer Nachbestrahlung bei operablem Rektumkarzinom. Strahlenter Onkol 1999; 175: 430-6. (C3/77)
61. Glimelius B, Isacsson U, Jung B, Påhlman L. Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose-response effect favouring preoperative treatment. Int J Radiat Oncol Biol Phys 1997; 37: 281-7. (O1)
62. Suwinski R, Taylor JMG, Withers HR. Rapid growth of microscopic rectal cancer as a determinant of response to preoperative radiation therapy. Int J Radiat Oncol Biol Phys 1998; 42: 943-51. (R1/3338)
63. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990; 264: 1444-50. (O1)
64. Cafiero F, Gipponi M, Peressini A, Bertoglio S, Lionetto R. Preliminary analysis of a randomized clinical trial of adjuvant postoperative RT vs. postoperative RT plus 5-FU and levamisole in patients with TNM stage II-III resectable rectal cancer. J Surg Oncol 2000; 75: 80-8. (C3/218)
65. Ragnhammar P, Hafström LO, Nygren P, Glimelius B. A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 2001; 40: 282-308. (O1)
66. Nygren P, Glimelius B. The Swedish Council on Technology Assessment in Health Care (SBU) report on Cancer Chemotherapy - project objectives, the working process, key definitions and general aspects on cancer trial methodology and interpretation. Acta Oncol 2001; 40: 155-65. (O1)
67. Letschert JGJ, Lebesque JV, de Boer RW, Hart AAM, Bartelink H. Dose-volume correlation in radiation-induced late small-bowel complications: a clinical study. Radiother Oncol 1990; 18: 307-20. (O1)
68. Frykholm-Jansson G, Isacsson U, Sintorn K, et al. Preoperative radiotherapy in rectal carcinoma - aspects of adverse effects and radiation technique. Int J Radiat Oncol Biol Phys 1996; 35: 1039-48. (O1)
69. Rouanet P, Fabre JM, Dubois JB, et al. Conservative surgery for low rectal carcinoma after high-dose radiation: functional and oncologic results. Ann Surg 1995; 221: 67-73. (P2/37)
70. Swedish Rectal Cancer Trial. Preoperative irradiation followed by surgery vs surgery alone in resectable rectal carcinoma - postoperative morbidity and mortality in a Swedish multicenter trial. Br J Surg 1993; 80: 1333-6. (C1/1147)
71. Holm T, Rutqvist LE, Johansson H, Cedermark B. Postoperative mortality in rectal cancer treated with or without preoperative radiotherapy: causes and risk factors. Br J Surg 1996; 83: 964-8. (C1/1027)
72. Holm T, Singnomklao T, Rutqvist L, Cedermark B. Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized trials. Cancer 1996; 78: 968-76. (C1/1027)
73. Bubrik MP, Rolfmeyers ES, Schauer RM, et al. Effects of high-dose and low-dose preoperative irradiation on low anterior anastomosis in dogs. Dis Colon Rectum 1982; 25: 406-15. (O1)
74. De Meerleer G, Pattyn P, Fortan L, et al. High-dose preoperative radiotherapy does not alter the strength of unilaterally irradiated colon anastomoses in rats. Int J Radiat Oncol Biol Phys 1999; 44: 163-70. (O1)
75. Frykholm-Jansson G, Sintorn K, Montelius A, Jung B, Påhlman L, Glimelius B. Acute lumbosacral plexopathy after preoperative radiotherapy in rectal carcinoma. Radiother Oncol 1996; 38: 121-30. (R1/550)
76. Miller RC, Martenson JA, Sargent DJ, Kahn MJ, Krook JE. Acute treatment-related diarrhea during postoperative adjuvant therapy for high-risk rectal carcinoma. Int J Radiat Oncol Biol Phys 1998; 41: 593-8. (C1/204)
77. Gunderson LL, Russell AH, Llewellyn HJ, Doppke KP, Tepper JE. Treatment planning for colorectal cancer: radiation and surgical techniques and value of small-bowel films. Int J Radiat Oncol Biol Phys 1985; 11: 1379-93. (O1)
78. Trimbos JB, Snijders G, Keilhold T, Peters AA. Feasibility of application of a resorbable polyglycolic-acid mesh (Dexon mesh) to prevent complications of radiotherapy following gynecological surgery. Eur J Surg 1991; 157: 281-4. (O2)
79. Mak AC, Rich TA, Schultheiss TE, Kavanagh B, Ota DM, Rosmdahl MM. Late complications of postoperative radiation therapy for cancer of the rectum and rectosigmoid. Int J Radiol Oncol Biol Phys 1994; 28: 597-603. (O1)
80. Kollmorgen CF, Meagher AP, Wolff BG, Pemberton JH, Matenson JA, Ilstrup DM. The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg 1994; 220: 676-82. (R3/100)
81. Lewis WG, Williamson MER, Stephenson BM, et al. Potential disadvantages of postoperative adjuvant radiotherapy after anterior resection for rectal cancer: a pilot study of sphincter function, rectal capacity and clinical outcome. Int J Colorectal Disease 1995; 10: 133-7. (L2)
82. Lundby L, Jensen VJ, Overgaard J, Lauerberg S. Long-term colorectal function after postoperative radiotherapy for colorectal cancer. Lancet 1997; 350: 564. (R2/84)
83. Dahlberg M, Glimelius B, Graf W, Påhlman L. Preoperative irradiation affects the functional results after surgery for rectal cancer. Dis Colon Rectum 1998; 41: 543-9. (C1/203)
84. Lundby L, Krogh K, Qvist N, et al. Severe late anorectal radiation morbidity following postoperative radiotherapy for rectal cancer - longtime results from a randomized trial. Radiother Oncol 2000; 57 (Suppl 1): abstr 25. (R3/84)
85. Beets-Tan R, Beets G, Vliegen R, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001; 357: 497-504. (O1)
86. Moertel CG, Childs DS Jr, Reitemeier RJ, et al. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969; 2: 865-7. (C3/65)
87. Rominger CJ, Gelber RD, Gunderson LL, Conner N. Radiation therapy alone or in combination with chemotherapy in the treatment of residual or inoperable carcinoma of the rectum and rectosigmoid or pelvic recurrence following colorectal surgery. Radiation Therapy Oncology Group study (76-16). Am J Clin Oncol 1985; 8: 118-27. (C3/147)
88. Overgaard M, Bertelsen K, Dalmark M, et al. A randomized feasibility study evaluating the effect of radiotherapy alone or combined with 5-fluorouracil in the treatment of locally recurrent or inoperable colorectal carcinoma. Acta Oncol 1993; 32: 547-53. (C3/59)
89. Danjoux CE, Gelber RD, Catton GE, Klaassen DJ. Combination chemoradiotherapy for residual, recurrent or inoperable carcinoma of the rectum: ECOG study (EST 3276). Int J Radiat Oncol Biol Phys 1985; 11: 765-71. (C3/30)
90. Minsky BD, Cohen AM, Kemeny N, et al. The efficacy of preoperative 5-fluorouracil, high dose leucovorin and sequential radiation therapy for unresectable rectal cancer. Cancer 1993; 71: 3486-92. (P2/20)
91. Marsh R de W, Chu NM, Vauthey JN, et al. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy. Cancer 1996; 78: 217-25. (P3/18)
92. De La Torre A, Ramos S, Valcárcel F, et al. Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1999; 45: 629-34. (P2/25)
93. Mohiuddin M, Regine WF, John WJ, et al. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. Int J Padiat Oncol Biol Phys 2000; 46: 883-8. (P2/33)
94. Videtic GMM, Fisher BJ, Perera FE, et al. Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1998; 42: 319-24. (P2/29)
95. Frykholm G, Glimelius B, Påhlman L. Preoperative irradiation with and without chemotherapy (MFL) in the treatment of primary non-resectable adenocarcinoma of the rectum. Results from two consecutive studies. Eur J Cancer Clin Oncol 1989; 25: 1535-41. (P1/59)
96. Chan A, Wong A, Langevin J, et al. Preoperative concurrent 5-FU infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma. Int J Radiat Oncol Biol Phys 1993; 25: 791-9.(P2/46)
97. Chan AKP, Wong AO, Langevin J, et al. Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study. Int J Radiat Oncol Biol Phys 2000; 48: 843-56. (P1/156)
98. Chan AKP, Wong AO, Langevin JM, et al. 'Sandwich' preoperative and postoperative combined chemotherapy and radiation in tethered and fixed rectal cancer: impact of treatment intensity on local control and survival. Int J Radiat Oncol Biol Phys 1997; 37: 629-37. (P2/27)
99. Movsas B, Hanlon AL, Lanciano R, et al. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 1998; 42: 43-50. (P3/27)
100. Thrall MM, Wood P, King V, Rivera W, Hrushesky W. Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2000; 46: 873-81. (R3/26)
101. Bosset JF, Magnin V, Maingon P, et al. Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial. Int J Radiat Oncol Biol Phys 2000; 46: 323-7. (P1/66)
102. Bosset JF, Pavy JJ, Hamers HP, et al. Determination of the optimal dose of 5-fluorouracil when combined with low dose d, 1-leucovorin and irradiation in rectal cancer: results of three consecutive phase II studies. EORTC Radiotherapy Group. Eur J Cancer 1993; 10: 1406-10. (P1/85)
103. Pfeiffer P, Jakobsen A. Concurrent UFT/1-leucovorin and high-dose radiotherapy (60 Gy) in patients with locally avanced rectal cancer (LARC): a phase I/II trial. Proc 11th NCI/EORTC/AACR Symp 2000; Amsterdam: 374 abstr. (P3/18)
104. Hoff PM, Janjan N, Saad ED, et al. Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer. J Clin Oncol 2000; 18: 3529-34. (P3/15)
105. Mehta V, Fisher G, Ford J, Edelstein P, JP. Preoperative chemoradiotherapy for ultrasound staged T3, T4 or N+ rectal cancer. 6th Int Congr Radiat Oncol Radiother Oncol 2001; 58: 123 abstr. (P3/28)
106. Dotor E, Munõz-Medina M, Navarro M, et al. Preoperative chemoradiotherapy (CHT-RDT) in locally advanced rectal cancer. Preliminary results. Ann Oncol 2000; 11: 230P abstr. (P3/90)
107. Botwood N, James R, Vernon C, Price P. Raltitrexed ('Tomudex') and radiotherapy can be combined as postoperative treatment for rectal cancer. Ann Oncol 2000; 11: 1023-8. (P3/22)
108. Carraro S, Roca E, Cartelli C, et al. Unresectable rectal cancer (URC): Oxaliplatin (OXA), 5-fluorouracil (5-FU) and leucovorin (LV) with concurrent radiotherapy (RT) followed by surgery. Preliminary results. Ann Oncol 2000; 11: 208 abstr. (P3/27)
109. Jansson-Frykholm G, Påhlman L, Glimelius B. Combined chemo- and radiotherapy vs radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 2001; 50: 427-34. (C3/70)
110. Anscher MS, Lee C, Hurwitz H, et al. A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer. Int J Radiat Oncol Biol Phys 2000; 47: 719-24. (P3/15)
111. Rodel C, Grabenbauer GG, Matzel KE, et al. Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer. Dis Colon Rectum 2000; 43: 312-9. (P2/35)
112. Tveit KM, Wiig JN, Olsen DR, Storaas A, Poulsen JP, Giercksky K-E. Combined modality treatment including intraoperative radiotherapy in locally advanced and recurrent rectal cancer. Radiother Oncol 1997; 44: 277-82. (P1/115)
113. Moertel CG, Gunderson LL, Cohen AM, et al. Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual or recurrent gatrointestinal carcinoma. J Clin Oncol 1994; 12: 21-7. (P3/10)
114. Harrison LB, Minsky BD, Enker WE, et al. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer. Int J Radiat Oncol Biol Phys 1998; 42: 325-30. (P1/112)
115. Freyer G, Bossard N, Romestaing P, et al. Addition of oxaliplatin to continuous fluorouracil, 1-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial. J Clin Oncol 2001; 19: 2433-8. (P3/17)
116. Allal AS, Bieri S, Pelloni A, et al. Sphincter-sparing surgery after preoperative radiotherapy for low rectal cancers: feasibility, oncologic results and quality of life outcomes. Br J Cancer 2000; 82: 1131-7. (R1/53)
117. Francois Y, Nemoz CJ, Baulieux J, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999; 17: 2396-402. (C2/201)
118. Bujko K, Nowacki M, Oledzki J, Sopylo R, Skoczylas J, Chwalinsky M. Sphincter preservation after short-term preoperative radiotherapy for low rectal cancer. Presentation of own data and a literature review. Acta Oncol 2001; 40: 593-601. (P1/108)
119. Wagman R, Minsky BD, Cohen AM, Guillem JG, Paty P. Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomis: long term follow-up. Int J Radiat Oncol Biol Phys 1998; 42: 51-7. (P2/36)
120. Grann A, Minsky BD, Cohen AM, et al. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum 1997; 40: 515-22. (P3/32)
121. Janjan NA, Khoo VS, Abbruzzese J, et al. Tumor down-staging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the MD Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 1999; 44: 1027-38. (P1/117)
122. Maghfoor I, Wilkes J, Kuvshinoff B, et al. Neoadjuvant chemoradiotherapy with sphincter-sparing surgery for low lying rectal cancer. Proc Am Soc Clin Oncol 1997; 16: 274 abstr. (P3/29)
123. Grann A, Feng C, Wong D, et al. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2001; 49: 987-95. (P1/72)
124. Ngan S, Fisher R, Rischin D, et al. Comparison of two regimens of protracted infusion 5-fluorouracil as part of preoperative chemoradiation treatment of resectable adenocarcinoma of rectum. Sixth Int Congr Radiat Oncol Radiother Oncol 2001; 58: 124 abstr. (P1/82)
125. Tamberi S, Minguzzi N, Emiliani E, et al. Preoperative radiation therapy with concurrent 5-fluorouracil (5-FU) in continuous infusion in distal rectal cancer: preliminary results. Ann Oncol 2000; 11: 232P abstr. (P3/29)
126. Russell AH, Harris J, Rosenberg PJ, et al. Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of Radiation Therapy Oncology Group protocol 89-02. Int J Radiat Oncol Biol Phys 2000; 46: 313-22.Comment in: Int J Radiat Oncol Biol Phys 2000;46: 267-8. (P1/65)
127. Russell AH, Harris J, Rosenberg PJ, et al. Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of Radiation Therapy Oncology Group protocol 89-02. Int J Radiat Oncol Biol Phys 2000; 46: 313-22.Comment in: Int J Radiat Oncol Biol Phys 2000;46: 267-8. (P1/65)
128. Valentini V, Coco C, Cellini N, et al. Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation. Int J Radiat Oncol Biol Phys 1999; 45: 1175-84. (P1/83)
129. Valentini V, Coco C, Cellini N, et al. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys 2001; 51: 371-83. (P1/163)
130. Shibata D, Guillem JG, Lanouette N, et al. Functional and quality-of-life outcomes in patients with rectal cancer after combined modality therapy, intraoperative radiation therapy, and sphincter preservation. Dis Colon Rectum 2000; 43: 752-8. (R2/18)
131. Marijnen CAM, Kapiteijn E, van de Velde CJ, et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2002; 3: 817-25. (C1/1861)
132. Stockholm Colorectal Cancer Study Group. Randomized study on preoperative radiotherapy in rectal carcinoma. Ann Surg Oncol 1996; 3: 423-30. (C1/849)